CREATION Knowledge

07.03.2023 | Article

Leading women are at the forefront of the oncology digital space

CREATION.co celebrates 5 female Digital Opinion Leaders Oncologists.

By Mary Kangley

06.03.2023 | Article

10 Ways to maximise your Congress Investment by utilising eHCP insights

Get greater insight into how to make the most of your congress investment

By Katie Kennedy

03.03.2023 | Article

Respiratory tracker: eHCPs are hopeful about declining flu and RSV numbers

Bringing you the latest insights into online HCPs' respiratory disease related conversation

By Mark Sullivan

05.02.2023 | Article

Product Launch Tracker: HCPs start the year discussing approvals for Alzheimer’s and…

Discover which new drug approvals HCPs are talking about

By Paul Cranston

31.01.2023 | Article

Lecanemab: Full phase 3 trial results for the Alzheimer’s disease drug not…

HCP conversations on Phase 3 trial data for lecanemab for Alzheimers has been shifting

By Francesca Gan

31.01.2023 | Article

The divided UK eHCP opinions on Medical Cannabis

Many see medical cannabis as an alternative medicine to relieve some patients symptoms

By Mark Sullivan

22.01.2023 | Article

Respiratory tracker: eHCPs focus on paediatric cases

An increased attention towards RSV by HCPs was noticed by CREATION in the last month

By Mark Sullivan

20.01.2023 | Article

“What if HCPs leave Twitter?” HCPs flock to Mastodon amid Twitter concerns

There is new trend in eHCP behaviour following the acquisition of Twitter by Elon Musk...

15.01.2023 | Article

Product Launch Tracker: HCPs discuss pre-Christmas approvals in precision medicine, oncology and…

At the start of the month, HCPs were interested in the first faecal microbiota product

By Paul Cranston

11.01.2023 | Article

The Top Pharma Events in 2023

2023 will see almost 90% of the events within the pharma industry being held in person

By Natalie Verghese

10.01.2023 | Press Release

Mary Fletcher-Louis joins leading eHCP Insights Consultancy

CREATION.co is delighted to announce that Mary Fletcher-Louis has joined the team as COO

05.01.2023 | Article

Top 50 Pharma Tracker: HCPs celebrate the Moderna and Merck combination melanoma…

The 5 companies mentioned the most by HCPs were Pfizer, Moderna, Johnson & Johnson....

By Francesca Gan